×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
1 V-0950 Protocol 001 Phase I FIM Safety/Immunogenicity Vaccine in AD Patient Recruitment and Retention Kathleen Oxberry Clinical Operations Specialist.
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form